April 22, 2024

K-Biotech Innovation Day with bioRN Life Science Cluster

K-Biotech Innovation Day with bioRN Life Science Cluster

Connecting Korean Biotech Innovation with the bioRN Life Science Ecosystem

BioRN Life Science Cluster and 123 Factory GmbH are pleased to invite you to the K-Biotech Innovation Day, an exclusive networking and partnering event bringing together innovative Korean biotech companies and members of the bioRN life science ecosystem.

On 17 September 2026, a delegation of five South Korean biotech and medtech startups will visit Heidelberg to explore potential collaboration opportunities with regional stakeholders. The companies will present their technologies, discuss potential partnership opportunities, and engage with representatives from academia, healthcare institutions, biotech companies, and industry.

The participating companies are actively seeking collaboration partners, clinical and research collaborators, distribution partners, licensing opportunities, and strategic business connections in Europe.

Date: 17 September 2026,14:30 – 18:00
Location:
Business Development Center (bdc) Carl-Friedrich-Gauß-Ring 5, 69124 Heidelberg
Target Audience: Biotech and Pharma Companies, Clinical Researchers, Academic Scientists, Healthcare Institutions, Investors, and Innovation Stakeholders

Meet the Delegating Startups

  1. AAVATAR Therapeutics | AI-Driven AAV Capsid Engineering Platform
    2. AIT Studio | AI-Based Digital Gait Analysis
    3. BICHEDAM | Oral Natural-Product Therapeutics
    4. BeyondDx | AI-Powered Multi-Omics Early Diagnostics
    5. LMNTIC Biotech | Micro-Magnetophoretic CTC Liquid Biopsy Platform

More information and links to websites in the document attached

Preliminary Agenda

14:30 – 15:30 | Introduction to the BioRN Life Science Ecosystem & Regional Strengths + Q&A
15:30 – 16:00 | Networking Coffee Break
16:00 – 17:00 | Startup Presentations / Speed Networking Session
17:00 – 18:00 | Open Networking

Why Attend?

This event offers a unique opportunity to:

  • Discover innovative Korean biotech and medtech technologies.
  • Explore opportunities for joint R&D and scientific collaboration.
  • Identify partners for clinical studies and validation projects.
  • Discuss licensing, commercialization, and market expansion opportunities.
  • Expand your international network within the Korean and European life science ecosystems.

Join us in Heidelberg to connect with Korea’s emerging biotech innovators and explore future collaboration opportunities.

register now

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp